Quantcast

FDA inspects LGM Pharma, LLC in Erlanger on June 28, 2024

 
FDA inspects LGM Pharma, LLC in Erlanger on June 28, 2024
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website

LGM Pharma, LLC in Erlanger was inspected by the Food and Drug Administration (FDA) on June 28, 2024 for the drug quality assurance, according to data posted on the FDA's website.

The final report indicated LGM Pharma, LLC should take voluntary action to correct the organization's managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.